Cardiff Oncology, Inc. (CRDF)

NASDAQ: CRDF · IEX Real-Time Price · USD
1.76
-0.01 (-0.56%)
Mar 17, 2023, 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2009
Revenue
0.390.360.370.240.380.510.380.310.280.26
Upgrade
Revenue Growth (YoY)
7.52%-1.91%49.61%-35.34%-25.14%32.63%21.82%11.65%8.07%-42.44%
Upgrade
Cost of Revenue
00000.61.811.730.630.020
Upgrade
Gross Profit
0.390.360.370.24-0.22-1.31-1.35-0.320.260.26
Upgrade
Selling, General & Admin
13.1811.848.225.768.0114.232314.368.547
Upgrade
Research & Development
27.1117.3811.2411.168.167.8815.0110.596.663.95
Upgrade
Other Operating Expenses
000-00.92.170.79000
Upgrade
Operating Expenses
40.2929.2119.4516.9217.0724.2938.824.9615.2110.95
Upgrade
Operating Income
-39.9-28.86-19.09-16.68-17.29-25.6-40.15-25.27-14.95-10.69
Upgrade
Interest Expense / Income
00000.031.031.671.470.830.02
Upgrade
Other Expense / Income
-1.2-0.560.22-0.26-0.85-1.72-2.620.73-1.451.1
Upgrade
Pretax Income
-38.7-28.29-19.31-16.41-16.46-24.91-39.2-27.47-14.33-11.81
Upgrade
Net Income
-38.7-28.29-19.31-16.41-16.46-24.91-39.2-27.47-14.33-11.81
Upgrade
Preferred Dividends
0.020.023.290.292.790.020.020.020.020.03
Upgrade
Net Income Common
-38.73-28.32-22.6-16.71-19.25-24.93-39.23-27.5-14.35-11.84
Upgrade
Shares Outstanding (Basic)
4439216200000
Upgrade
Shares Outstanding (Diluted)
4439216200000
Upgrade
Shares Change
11.71%86.97%249.44%156.37%383.77%14.53%14.48%38.70%12.33%29.94%
Upgrade
EPS (Basic)
-0.89-0.73-1.08-2.80-8.26-51.76-93.60-75.60-54.72-50.40
Upgrade
EPS (Diluted)
-0.89-0.73-1.08-2.80-8.26-51.76-93.30-87.12-63.36-50.40
Upgrade
Free Cash Flow Per Share
-0.80-0.60-0.79-2.23-5.66-48.54-76.03-66.92-49.62-33.78
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%-57.92%-258.41%-354.12%-101.14%94.49%100.00%
Upgrade
Operating Margin
-10337.31%-8037.60%-5214.75%-6816.98%-4570.21%-5064.42%-10534.91%-8079.50%-5334.17%-4123.71%
Upgrade
Profit Margin
-10033.16%-7887.19%-6174.32%-6829.31%-5089.53%-4932.88%-10294.11%-8789.73%-5121.21%-4567.39%
Upgrade
Free Cash Flow Margin
-9022.28%-6474.93%-4515.30%-5451.09%-3482.77%-4626.13%-8361.50%-7785.02%-4649.61%-3072.96%
Upgrade
EBITDA
-38.47-27.84-18.84-15.92-15.58-22.63-36.46-25.62-13.26-11.66
Upgrade
EBITDA Margin
-9965.80%-7754.87%-5147.27%-6507.70%-4117.17%-4476.66%-9567.70%-8191.55%-4732.58%-4498.98%
Upgrade
Depreciation & Amortization
0.240.450.470.490.861.251.070.380.230.13
Upgrade
EBIT
-38.7-28.29-19.31-16.41-16.44-23.87-37.53-26-13.49-11.79
Upgrade
EBIT Margin
-10026.94%-7880.50%-5274.59%-6709.74%-4344.35%-4723.51%-9848.37%-8312.62%-4816.39%-4549.32%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).